With a strong demand Growth in thehealthcarespace and people focusing more on preventative care after the outbreak of Covid-19 pandemic, pharma companies are adding more drugs and products to their existing portfolios.
As a result, there has been a substantial jump in productapprovalsgranted to manufacture medicines inGujarat.
For instance: Gujarat Food and Drug Control Administration (FDCA) in September issued 5,494 licences to make different allopathic drugs and products. Except January and April, the number of product permissions provided to pharma firms every month has hovered above the 5,000-mark this year, shows data compiled by the FDCA-Gujarat.
While exports of pharmaceuticals have been robust ever since the pandemic struck, the domestic market growth has also bounced back strongly. This has prompted more and more companies to launch their products to cater to the growing demand, added players.